Raymond James Financial Inc. Takes Position in Invesco Pharmaceuticals ETF (NYSEARCA:PJP)

Raymond James Financial Inc. acquired a new position in shares of Invesco Pharmaceuticals ETF (NYSEARCA:PJP) in the 4th quarter, according to the company in its most recent filing with the SEC. The fund acquired 11,415 shares of the company’s stock, valued at approximately $943,000. Raymond James Financial Inc. owned approximately 0.34% of Invesco Pharmaceuticals ETF as of its most recent SEC filing.

A number of other hedge funds and other institutional investors also recently bought and sold shares of the company. FMR LLC boosted its holdings in Invesco Pharmaceuticals ETF by 29.4% in the third quarter. FMR LLC now owns 1,057 shares of the company’s stock worth $92,000 after acquiring an additional 240 shares in the last quarter. Jones Financial Companies Lllp boosted its stake in Invesco Pharmaceuticals ETF by 195.7% in the 4th quarter. Jones Financial Companies Lllp now owns 2,176 shares of the company’s stock worth $180,000 after purchasing an additional 1,440 shares in the last quarter. MGB Wealth Management LLC grew its position in Invesco Pharmaceuticals ETF by 11.9% during the 4th quarter. MGB Wealth Management LLC now owns 21,976 shares of the company’s stock worth $1,815,000 after purchasing an additional 2,345 shares during the last quarter. JPMorgan Chase & Co. increased its stake in Invesco Pharmaceuticals ETF by 241.7% during the 3rd quarter. JPMorgan Chase & Co. now owns 4,046 shares of the company’s stock valued at $352,000 after purchasing an additional 2,862 shares in the last quarter. Finally, Grimes & Company Inc. purchased a new position in shares of Invesco Pharmaceuticals ETF in the fourth quarter worth $354,000.

Invesco Pharmaceuticals ETF Stock Down 4.9 %

Shares of NYSEARCA:PJP opened at $78.60 on Friday. Invesco Pharmaceuticals ETF has a 52-week low of $75.33 and a 52-week high of $89.87. The stock has a market cap of $238.16 million, a price-to-earnings ratio of 21.82 and a beta of 0.56. The business has a 50-day moving average price of $85.59 and a 200-day moving average price of $85.58.

Invesco Pharmaceuticals ETF Increases Dividend

The firm also recently declared a dividend, which was paid on Friday, March 28th. Shareholders of record on Monday, March 24th were issued a $0.2729 dividend. This is a positive change from Invesco Pharmaceuticals ETF’s previous dividend of $0.21. The ex-dividend date of this dividend was Monday, March 24th.

Invesco Pharmaceuticals ETF Company Profile

PowerShares Dynamic Pharmaceuticals Portfolio (the Fund) is a non-diversified fund. The Fund seeks investment results that correspond generally to the price and yield of the Dynamic Pharmaceuticals Intellidex Index (the Index). The Index evaluates companies based on a variety of investment merit criteria, including fundamental growth, stock valuation, investment timeliness and risk factors.